SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 220 filers reported holding SAGE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $523 | -16.2% | 11,120 | -25.2% | 0.07% | +13.8% |
Q1 2023 | $624 | -99.9% | 14,876 | -10.8% | 0.06% | -4.9% |
Q2 2022 | $539,000 | +54.4% | 16,680 | +258.1% | 0.06% | +56.4% |
Q1 2021 | $349,000 | +4.5% | 4,658 | -60.0% | 0.04% | -40.0% |
Q1 2020 | $334,000 | +7.1% | 11,646 | +424.1% | 0.06% | +18.2% |
Q3 2019 | $312,000 | +10.2% | 2,222 | +43.5% | 0.06% | +14.6% |
Q2 2019 | $283,000 | -76.7% | 1,548 | -82.0% | 0.05% | -71.4% |
Q3 2018 | $1,213,000 | +70.8% | 8,587 | +99.4% | 0.17% | +33.3% |
Q4 2017 | $710,000 | +18.7% | 4,306 | -42.7% | 0.13% | +11.5% |
Q2 2017 | $598,000 | +196.0% | 7,513 | +164.4% | 0.11% | +140.4% |
Q1 2017 | $202,000 | – | 2,842 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
Diametric Capital, LP | 19,393 | $626,000 | 0.46% |